Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs.
about
A biomechanical, micro-computertomographic and histological analysis of the influence of diclofenac and prednisolone on fracture healing in vivo.The effects of ketorolac injected via patient controlled analgesia postoperatively on spinal fusionMonitoring tissue inflammation and responses to drug treatments in early stages of mice bone fracture using 50 MHz ultrasoundFracture healing and lipid mediators.Effect of Non-Steroidal Anti-Inflammatory Drugs on Bone HealingThe spatiotemporal role of COX-2 in osteogenic and chondrogenic differentiation of periosteum-derived mesenchymal progenitors in fracture repair.Microarray Analysis of Gene Expression Reveals that Cyclo-oxygenase-2 Gene Therapy Up-regulates Hematopoiesis and Down-regulates Inflammation During Endochondral Bone Fracture Healing.Modulation of the inflammatory response for enhanced bone tissue regenerationThe Effect of Perioperative Ketorolac on the Clinical Failure Rate of Meniscal Repair.Role of Fas and Treg cells in fracture healing as characterized in the fas-deficient (lpr) mouse model of lupus.Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activityAntagonism of nerve growth factor-TrkA signaling and the relief of painImmunohistochemical localization of key arachidonic acid metabolism enzymes during fracture healing in mice.Systems pharmacology dissection of the anti-inflammatory mechanism for the medicinal herb Folium eriobotryae.Strategies Aimed at Preventing Chronic Post-surgical Pain: Comprehensive Perioperative Pain Management after Total Joint Replacement SurgeryThe role of polyunsaturated ω-3 fatty acid eicosapentaenoic acid-derived resolvin E1 (RvE1) in bone preservation.The Effect of Cyclooxygenase Inhibition on Tendon-Bone Healing in an In Vitro Coculture ModelNew advances in musculoskeletal pain.Reduced COX-2 expression in aged mice is associated with impaired fracture healing.Low-dose TNF augments fracture healing in normal and osteoporotic bone by up-regulating the innate immune response.Preliminary study on the effect of parenteral naloxone, alone and in association with calcium gluconate, on bone healing in an ovine "drill hole" model system.Effects of Remifentanil Preconditioning on Osteoblasts under Hypoxia-Reoxygenation Condition.Making progress in the management of postoperative pain: a review of the cyclooxygenase 2-specific inhibitors.Pain management for dentists: the role of ibuprofen.Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing.Hypoxia-induced HMGB1 in would tissues promotes the osteoblast cell proliferation via activating ERK/JNK signalingThe prostaglandin E2 receptor, EP2, is upregulated in the dorsal root ganglion after painful cervical facet joint injury in the rat.Ketorolac reduces spinal astrocytic activation and PAR1 expression associated with attenuation of pain after facet joint injury.Measurement of fracture callus material properties via nanoindentationAssessment of modified gold surfaced titanium implants on skeletal fixation.Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process.The rat model of femur fracture for bone and mineral research: An improved description of expected comminution, quantity of soft callus and incidence of complicationsEffects of a selective cyclooxygenase-2 inhibitor (celecoxib) on fracture healing in rats.COX-2 from the injury milieu is critical for the initiation of periosteal progenitor cell mediated bone healingParecoxib and indomethacin delay early fracture healing: a study in rats.Rescue of impaired fracture healing in COX-2-/- mice via activation of prostaglandin E2 receptor subtype 4.Parecoxib has non-significant long-term effects on bone healing in rats when administered for a short period after fracture.Capsaicin-sensitive sensory nerve fibers contribute to the generation and maintenance of skeletal fracture pain.Human immune cells' behavior and survival under bioenergetically restricted conditions in an in vitro fracture hematoma model.Room for improvement: unmet needs in postoperative pain management.
P2860
Q27309225-81EB780F-2D62-45BE-8954-190516FEC42CQ28174517-263407DF-EFEB-4416-96A8-3B98B845AAC0Q30437119-4A955606-23CB-45D6-9912-3197E460F796Q33554902-F344388E-B8F7-43E7-B5E9-335D3676A0B0Q33664353-CD613C09-72EB-4005-AB95-CBA26527BA75Q33837902-0C6FC278-5107-48B9-A038-7EDCD6E489DDQ34219169-F5E94411-17AC-4CAD-B733-CD39159B96E2Q34234144-B959D0D7-511F-4F06-8B69-0A2385209CDAQ34494065-64D59019-248C-4260-9E5C-BCDA70DC8BE9Q35008584-FE592D6A-5723-495E-8E1B-7DA6FA8ED9AFQ35029163-53D7E871-D4ED-4DC1-8759-69E0AC7904D8Q35064559-0499F30C-8C8F-4F69-80F9-048D6D15BF0CQ35091768-88C2937F-B43D-4A6E-831B-AC52087E9A73Q35138964-29158B36-6B1C-4516-8109-8B83496EF9F2Q35170290-F8D449F3-36B0-4FA0-9285-421FCB1C3066Q35246409-A36DE269-3D26-4917-83B8-6E5462C0321AQ35625895-84210B5A-8868-42D4-8716-BE940112652AQ35701568-904AE91E-BCB3-4EB7-871A-9637D51BD2D8Q35748166-862D34C3-D06F-4055-918E-5C33D620B907Q35822559-04133C84-F562-4463-AA4F-1F463A397D02Q35840233-D68E7ACD-E6B3-4ADC-B8B0-FCD3483BF3C3Q35942081-C5912931-7702-49CF-A327-3AB419E71DD3Q35976831-5882DA55-A871-4281-80AB-FA9FEA6C6397Q36148700-47714AC0-0FB9-46C3-AD48-AAAA9DCA6441Q36289418-CB231248-7DE9-405D-9E6F-0B0FE40B3090Q36317424-89E11AB0-3ABE-4C4B-9160-501ACA557DC0Q36405804-752174F2-EF04-4C2C-A488-6EFDAEEE1A9AQ36862960-500252E9-0945-44C4-8BE1-138F625E00CDQ36953988-24981B12-7A70-42DE-B123-F27FFE3015E7Q36957187-76313769-BA09-4CF1-807E-80B595F3E3EDQ36987298-E8C70178-9968-41E6-A5CE-0E08EAECAF2FQ37095172-2593C673-A69F-44EE-9BB0-4CB044229645Q37100521-A11DA396-FD47-44A2-9FC7-B99E8477461FQ37172205-3719BBEE-DD4E-42A6-BE3C-9AB7636FC1DDQ37251966-9996C0B3-A91F-4776-94CD-9ED8629B2ACEQ37278490-35CA6D98-FFF4-46BE-A96D-E4C6E8514AD3Q37313416-1B7F50F3-74A4-4642-AE3D-2B2914879DDEQ37398720-D69408FD-8792-4AA3-A571-530947BA915DQ37729352-A88D4276-074E-4452-AC57-35AE25699FF5Q38006982-3B2176FD-B44C-42FB-A579-A1429F742192
P2860
Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Differential inhibition of fra ...... oidal anti-inflammatory drugs.
@en
Differential inhibition of fra ...... oidal anti-inflammatory drugs.
@nl
type
label
Differential inhibition of fra ...... oidal anti-inflammatory drugs.
@en
Differential inhibition of fra ...... oidal anti-inflammatory drugs.
@nl
prefLabel
Differential inhibition of fra ...... oidal anti-inflammatory drugs.
@en
Differential inhibition of fra ...... oidal anti-inflammatory drugs.
@nl
P2093
P1476
Differential inhibition of fra ...... oidal anti-inflammatory drugs.
@en
P2093
Bohus Svagr
Cindy Mielke
Deborah Phippard
Dennis Cullinane
Karen Seibert
Louis C Gerstenfeld
Mark Thiede
P304
P356
10.1016/S0736-0266(03)00003-2
P577
2003-07-01T00:00:00Z